| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
An association of sarcoidosis with hepatocellular carcinoma
|
Chalasani, P.
|
|
|
16 |
10 |
p. 1714-1715
|
article
|
| 2 |
A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer
|
Oettle, H.
|
|
|
16 |
10 |
p. 1639-1645
|
article
|
| 3 |
Can tamoxifen relieve motion sickness?
|
Gianni, L.
|
|
|
16 |
10 |
p. 1713-1714
|
article
|
| 4 |
Cerebrospinal fluid diffusion of Zevalin® after high-activity treatment and stem cell support in a patient affected by diffuse large B-cell non-Hodgkin's lymphoma with central nervous system involvement
|
Ferrucci, P.F.
|
|
|
16 |
10 |
p. 1710-1711
|
article
|
| 5 |
Cisplatin and gemcitabine in malignant mesothelioma
|
Nowak, A.K.
|
|
|
16 |
10 |
p. 1711
|
article
|
| 6 |
Comparative effects of anastrozole, tamoxifen alone and in combination on plasma lipids and bone-derived resorption during neoadjuvant therapy in the impact trial
|
Banerjee, S.
|
|
|
16 |
10 |
p. 1632-1638
|
article
|
| 7 |
Doing cancer trials in India: opportunities and pitfalls
|
Raina, V.
|
|
|
16 |
10 |
p. 1567-1568
|
article
|
| 8 |
Dose-finding study of weekly docetaxel, anthracyclines plus fluoropyrimidines as first-line treatment in advanced breast cancer
|
Pagani, O.
|
|
|
16 |
10 |
p. 1609-1617
|
article
|
| 9 |
Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage IA lymphocyte-predominant Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Study Group (GHSG)
|
Nogová, L.
|
|
|
16 |
10 |
p. 1683-1687
|
article
|
| 10 |
Imatinib and hydroxyurea in pretreated progressive glioblastoma multiforme: a patient series
|
Dresemann, G.
|
|
|
16 |
10 |
p. 1702-1708
|
article
|
| 11 |
In this Issue
|
|
|
|
16 |
10 |
p. 1563
|
article
|
| 12 |
Is the gefitinib plus trastuzumab combination feasible in breast cancer patients?
|
Normanno, N.
|
|
|
16 |
10 |
p. 1709
|
article
|
| 13 |
Lung cancer mortality in European women: recent trends and perspectives
|
Bosetti, C.
|
|
|
16 |
10 |
p. 1597-1604
|
article
|
| 14 |
Meeting Highlights: International Expert Consensus on the Primary Therapy of Early Breast Cancer 2005
|
Goldhirsch, A.
|
|
|
16 |
10 |
p. 1569-1583
|
article
|
| 15 |
Phase I study to determine the safety and pharmacokinetics of the novel Raf kinase and VEGFR inhibitor BAY 43-9006, administered for 28 days on/7 days off in patients with advanced, refractory solid tumors
|
Moore, M.
|
|
|
16 |
10 |
p. 1688-1694
|
article
|
| 16 |
Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase protein expression on survival in adjuvantly treated stage III colon cancer patients
|
Westra, J.L.
|
|
|
16 |
10 |
p. 1646-1653
|
article
|
| 17 |
Preventing the lung cancer epidemic
|
Boyle, P.
|
|
|
16 |
10 |
p. 1565-1566
|
article
|
| 18 |
Primary chemotherapy with gemcitabine as prolonged infusion, non-pegylated liposomal doxorubicin and docetaxel in patients with early breast cancer: final results of a phase II trial
|
Schmid, P.
|
|
|
16 |
10 |
p. 1624-1631
|
article
|
| 19 |
PS-341 and gemcitabine in patients with metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group (NCCTG) randomized phase II study
|
Alberts, S.R.
|
|
|
16 |
10 |
p. 1654-1661
|
article
|
| 20 |
Recombinant human endostatin administered as a 28-day continuous intravenous infusion, followed by daily subcutaneous injections: a phase I and pharmacokinetic study in patients with advanced cancer
|
Hansma, A.H.G.
|
|
|
16 |
10 |
p. 1695-1701
|
article
|
| 21 |
Recombinant human erythropoietin in oncology: current status and further developments
|
Engert, A.
|
|
|
16 |
10 |
p. 1584-1595
|
article
|
| 22 |
Reply to the article “The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancer” by K. P. Weinfurt et al. (Ann Oncol 2005; 16: 579–584)
|
Tanvetyanon, T.
|
|
|
16 |
10 |
p. 1712-1713
|
article
|
| 23 |
Scope and significance of non-uniform classification practices in breast cancer with non-inflammatory skin involvement: a clinicopathologic study and an international survey
|
Güth, U.
|
|
|
16 |
10 |
p. 1618-1623
|
article
|
| 24 |
Single agent rituximab in patients with follicular or mantle cell lymphoma: clinical and biological factors that are predictive of response and event-free survival as well as the effect of rituximab on the immune system: a study of the Swiss Group for Clinical Cancer Research (SAKK)
|
Ghielmini, M.
|
|
|
16 |
10 |
p. 1675-1682
|
article
|
| 25 |
Smoking and lung cancer in Harbin, northeast China
|
Hu, J.
|
|
|
16 |
10 |
p. 1605-1608
|
article
|
| 26 |
Table of Contents
|
|
|
|
16 |
10 |
p. i-ii
|
article
|
| 27 |
Three-year findings of an early lung cancer detection feasibility study with low-dose spiral computed tomography in heavy smokers
|
Novello, S.
|
|
|
16 |
10 |
p. 1662-1666
|
article
|
| 28 |
Trichomegaly of the eyelashes following treatment with cetuximab
|
Bouché, O.
|
|
|
16 |
10 |
p. 1711-1712
|
article
|
| 29 |
VEGF inhibition and cytotoxic effect of aplidin in leukemia cell lines and cells from acute myeloid leukemia
|
Biscardi, M.
|
|
|
16 |
10 |
p. 1667-1674
|
article
|
Journal description